The lamellar ichthyosis treatment Market is supported by continued research into therapies that can reduce hyperkeratosis and improve the function of the skin barrier. Because lamellar ichthyosis can persist throughout life, patients often require consistent skincare and medical management.

Topical therapies remain important because they can be incorporated into daily skincare routines. Emollients and keratolytic agents can help reduce dryness and scaling, while selected topical retinoids may be used to address more persistent hyperkeratotic areas.

Systemic retinoids such as acitretin and isotretinoin can provide an option for patients with more severe manifestations. However, their use requires careful consideration of potential adverse effects and appropriate medical monitoring, particularly during long-term treatment.

Future market development is likely to focus on improving treatment tolerability and convenience. New formulations, optimized dosing strategies, and therapies that address the underlying biology of abnormal keratinization could expand options for patients with difficult-to-manage disease.